🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK557296 is being studied in women for the indication of enhanced embryo a...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-16
Trial ID
NCT01669083
Treatments Being Tested
This multi-cohort phase I study is designed to assess the pharmacokinetics ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-08-28
Trial ID
NCT02213029
Treatments Being Tested
The current study is designed to assess the safety, tolerability and pharma...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-07-09
Trial ID
NCT02703181
Treatments Being Tested
Epelsiban is a potent and selective oxytocin receptor antagonist in develop...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-18
Trial ID
NCT02257359
Treatments Being Tested
A study conducted on healthy volunteers to determine the safety, tolerabili...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10
Trial ID
NCT00549211
Treatments Being Tested
To determine if an on demand dosing of 50 mg or 150 mg of GSK557296 demonst...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-12-23
Trial ID
NCT01021553